Procter & Gamble Hygiene and Health Care Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Procter & Gamble Hygiene and Health Care has been growing earnings at an average annual rate of 8.6%, while the Personal Products industry saw earnings growing at 8.6% annually. Revenues have been growing at an average rate of 7.1% per year. Procter & Gamble Hygiene and Health Care's return on equity is 87.3%, and it has net margins of 16.1%.
Belangrijke informatie
8.6%
Groei van de winst
8.6%
Groei van de winst per aandeel
Personal Products Groei van de industrie | 7.9% |
Inkomstengroei | 7.1% |
Rendement op eigen vermogen | 87.3% |
Nettomarge | 16.1% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Procter & Gamble Hygiene and Health Care geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 42,025 | 6,762 | 8,299 | 0 |
30 Jun 24 | 42,057 | 6,750 | 8,136 | 0 |
31 Mar 24 | 41,265 | 7,452 | 6,854 | 0 |
31 Dec 23 | 40,074 | 7,559 | 6,473 | 0 |
30 Sep 23 | 40,114 | 7,344 | 6,426 | 0 |
30 Jun 23 | 39,179 | 6,781 | 6,233 | 0 |
31 Mar 23 | 38,418 | 5,695 | 6,628 | 0 |
31 Dec 22 | 39,319 | 5,073 | 6,751 | 0 |
30 Sep 22 | 38,875 | 5,119 | 7,059 | 0 |
30 Jun 22 | 39,009 | 5,758 | 6,785 | 0 |
31 Mar 22 | 39,111 | 5,822 | 7,712 | 0 |
31 Dec 21 | 36,975 | 5,777 | 7,895 | 0 |
30 Sep 21 | 36,230 | 6,162 | 7,409 | 0 |
30 Jun 21 | 35,741 | 6,518 | 7,130 | 0 |
31 Mar 21 | 34,221 | 6,720 | 5,542 | 0 |
31 Dec 20 | 33,185 | 6,648 | 4,926 | 0 |
30 Sep 20 | 31,593 | 5,501 | 4,936 | 0 |
30 Jun 20 | 30,020 | 4,331 | 4,885 | 0 |
31 Mar 20 | 30,048 | 4,247 | 5,655 | 0 |
31 Dec 19 | 30,480 | 4,237 | 5,454 | 0 |
30 Sep 19 | 30,068 | 4,119 | 5,211 | 0 |
30 Jun 19 | 29,469 | 4,191 | 4,803 | 0 |
31 Mar 19 | 28,339 | 4,029 | 4,707 | 0 |
31 Dec 18 | 27,034 | 3,960 | 4,710 | 0 |
30 Sep 18 | 25,895 | 4,031 | 4,410 | 0 |
30 Jun 18 | 24,553 | 3,746 | 4,039 | 0 |
31 Mar 18 | 24,335 | 4,081 | 3,390 | 0 |
31 Dec 17 | 24,385 | 4,245 | 3,213 | 0 |
30 Sep 17 | 23,776 | 4,439 | 3,065 | 0 |
30 Jun 17 | 23,204 | 4,327 | 3,242 | 0 |
31 Mar 17 | 25,574 | 4,647 | 3,233 | 0 |
31 Dec 16 | 25,277 | 4,622 | 3,146 | 0 |
30 Sep 16 | 25,433 | 4,581 | 3,177 | 0 |
30 Jun 16 | 22,754 | 4,225 | 3,332 | 0 |
31 Mar 16 | 24,823 | 4,209 | 6,716 | 0 |
31 Dec 15 | 24,233 | 4,105 | 6,846 | 0 |
30 Sep 15 | 23,543 | 3,544 | 8,263 | 0 |
30 Jun 15 | 23,323 | 3,461 | 3,035 | 0 |
31 Mar 15 | 22,601 | 3,290 | 6,205 | 0 |
31 Dec 14 | 22,056 | 3,228 | 6,236 | 0 |
30 Sep 14 | 21,321 | 3,087 | 6,414 | 0 |
30 Jun 14 | 20,486 | 3,020 | 6,074 | 0 |
31 Mar 14 | 19,886 | 2,640 | 5,738 | 0 |
31 Dec 13 | 19,049 | 2,353 | 5,585 | 0 |
Kwaliteitswinsten: 500459 has high quality earnings.
Groeiende winstmarge: 500459's current net profit margins (16.1%) are lower than last year (18.3%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 500459's earnings have grown by 8.6% per year over the past 5 years.
Versnelling van de groei: 500459's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 500459 had negative earnings growth (-7.9%) over the past year, making it difficult to compare to the Personal Products industry average (21.9%).
Rendement op eigen vermogen
Hoge ROE: 500459's Return on Equity (87.3%) is considered outstanding.